From the prognostic analysis of lung cancer database, the median survival time of patients with high SIPA1 expression was significantly shorter than that of patients with low SIPA1 expression, and the difference is particularly significant in patients with adenocarcinoma. This evidence concerns the gene SIPA1 and adenocarcinoma.